Abstract:Background
Kawasaki disease (KD) is an acute systemic vasculitis that predominantly affects patients younger than 5 years. In the absence of an available, affordable diagnostic test, detailed clinical history and physical examination are still fundamental to make a diagnosis.
Methods
We present five representative cases with KD‐like presentations: systemic onset juvenile idiopathic arthritis, mycoplasma‐induced rash and mucositis, staphylococcal scalded skin syndrome, BCGosis, and the recently described multis… Show more
“…Similarly, the use of hyper-immune serum from recovered patients was indicated among the successful therapeutic interventions during the SARS outbreak [29] and was apparently rediscovered, as a new and innovative strategy, during the COVID-19 pandemic. Also the increased incidence of Kawasaki-like disease (or rather "syndrome" as this clinical presentation of the SARS-CoV-2 infection in children is now called), had been described during the SARS outbreak, and has occurred again during the COVID-19 pandemic [30], as should have been expected, given the much larger prevalence of the infection.…”
“…Similarly, the use of hyper-immune serum from recovered patients was indicated among the successful therapeutic interventions during the SARS outbreak [29] and was apparently rediscovered, as a new and innovative strategy, during the COVID-19 pandemic. Also the increased incidence of Kawasaki-like disease (or rather "syndrome" as this clinical presentation of the SARS-CoV-2 infection in children is now called), had been described during the SARS outbreak, and has occurred again during the COVID-19 pandemic [30], as should have been expected, given the much larger prevalence of the infection.…”
“…In einzelnen Fallberichten wurden weitere Hautmanifestationen beschrieben. So zeigte sich bei Patienten mit PIMS ebenso eine Purpura im Rahmen einer Ig(Immunglobulin)A-Vaskulitis [ 16 ], und in einem weiteren Fall wurden lokalisierte Hautexantheme im Genitalbereich und an den Füßen beschrieben [ 43 ].…”
“…Bei Auftreten von PIMS ist die SARS-CoV-2-PCR meist bereits negativ und die Serologie positiv für SARS-CoV-2-Antikörper. Im Routinelabor zeigen sich die Entzündungsparameter (CRP, BSG, Ferritin) stark erhöht sowie eine Lymphopenie und Thrombozytopenie, ebenso erhöhte D‑Dimere [ 43 , 56 ]. Bei Vorliegen einer kardialen Beteiligung können das nt-proBNP sowie Troponin erhöht sein.…”
Virale und paravirale Exantheme sind die häufigsten Exantheme des Kindesalters, die auch meist zu einer Vorstellung in der Praxis inklusive der Notaufnahme führen. Die Kenntnis der verschiedenen Krankheitsbilder ist entscheidend für die adäquate Diagnostik und Betreuung der kleinen Patient:innen, die entsprechende Aufklärung der Familie und ggf. das Minimieren des Infektionsrisikos. In der aktuellen Arbeit werden die kürzlich beschriebenen „reactive infectious mucocutaneous eruptions“ (RIME) und das „pediatric inflammatory multisystem syndrome“ (PIMS) vorgestellt. Zusätzlich werden wir einige atypische Manifestationen des Gianotti-Crosti-Syndroms und der Hand-Fuß-Mund-Erkrankung – wie z. B. die mit Mollusken assoziierte „Gianotti-Crosti-like reaction“ und das „eczema coxsackium“ – erläutern.
“…KD and so-JIA share many common clinical and laboratory features. So-JIA can be initially diagnosed as KD and vice versa (123)(124)(125). CAL can be also found in soJIA.…”
Kawasaki disease (KD), an acute, generalized vasculitis, is associated with an increased risk of coronary heart disease and is the most common cause of acquired heart disease in childhood. The incidence of KD is increasing worldwide. There are numerous international treatment guidelines. Our study aims to perform the first one so far comparison of them. While the gold standard therapy remains still the same (intravenous immunoglobulins and aspirin), there is currently a lack of evidence for choosing optimal treatment for high-risk patients and refractory KD. In this review, we also discuss the treatment of complications of KD and Kawasaki-like phenotypes, present an anti-inflammatory treatment in the light of new scientific data, and present novel potential therapeutic targets for KD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.